User profiles for E. N. Jonsson

Niclas Jonsson

Pharmetheus AB
Verified email at pharmetheus.com
Cited by 7339

Xpose—an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

EN Jonsson, MO Karlsson - Computer methods and programs in …, 1998 - Elsevier
The building of population pharmacokinetic/pharmacodynamic (PK/PD) models is a time
consuming and complicated task. This is partly due the lack of specialized tools for the …

Perl-speaks-NONMEM (PsN)—a Perl module for NONMEM related programming

L Lindbom, J Ribbing, EN Jonsson - Computer methods and programs in …, 2004 - Elsevier
The NONMEM program is the most widely used nonlinear regression software in population
pharmacokinetic/pharmacodynamic (PK/PD) analyses. In this article we describe a …

Automated covariate model building within NONMEM

EN Jonsson, MO Karlsson - Pharmaceutical research, 1998 - Springer
Purpose. One important task in population pharmacokinetic/pharmacodynamic model
building is to identify the relationships between the parameters and demographic factors (…

Assessment of actual significance levels for covariate effects in NONMEM

U Wählby, EN Jonsson, MO Karlsson - Journal of pharmacokinetics and …, 2001 - Springer
The objectives of this study were to assess the difference between actual and nominal
significance levels, as judged by the likelihood ratio test, for hypothesis tests regarding covariate …

Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis

U Wählby, EN Jonsson, MO Karlsson - Aaps Pharmsci, 2002 - Springer
The aim of this study was to compare 2 stepwise covariate model-building strategies,
frequently used in the analysis of pharmacokinetic-pharmacodynamic (PK-PD) data using …

A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy

…, V Pengo, R Padrini, EN Jonsson - Clinical …, 2007 - Wiley Online Library
The aim of this study was to characterize the relationship between warfarin concentrations
and international normalized ratio (INR) response and to identify predictors important for dose …

Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients

MO Karlsson, EN Jonsson, CG Wiltse… - … of pharmacokinetics and …, 1998 - Springer
Deriving a population pharmacokinetic model from real data is always associated with
numerous assumptions. Violations of these assumptions, especially if undetected, may lead to …

Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: Kp, Kp, u, and Kp, uu

…, P Chatelain, R Massingham, EN Jonsson… - Drug metabolism and …, 2006 - ASPET
The objective of this study was to compare the blood-brain barrier (BBB) transport and brain
distribution of levo- (R-CZE) and dextrocetirizine (S-CZE). Microdialysis probes, calibrated …

A comprehensive hepatitis C viral kinetic model explaining cure

…, M Lavielle, P Jacqmin, EN Jonsson… - Clinical …, 2010 - Wiley Online Library
We propose a model that characterizes and links the complexity and diversity of clinically
observed hepatitis C viral kinetics to sustained virologic response (SVR)—the primary clinical …

A Pharmacometric Model Describing the Relationship Between Warfarin Dose and INR Response With Respect to Variations in CYP2C9, VKORC1, and Age

…, P Deloukas, A Rane, EN Jonsson - Clinical …, 2010 - Wiley Online Library
The objective of the study was to update a previous NONMEM model to describe the relationship
between warfarin dose and international normalized ratio (INR) response, to decrease …